Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Pharma & Biotech

Cell and Gene Therapy Service Market Opportunity Assessment

A startup wanted to understand how customers could use its cutting-edge technology and which applications to target for further development

Voice-of-Customer Research

Pre-due diligence research on a potential acquisition target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help